# Lupin Pharmaceuticals Inc., Baltimore, MD – FDA Inspections

Source: https://www.keypedia.com/companies/lupin-pharmaceuticals-inc/5bd476cf-32c9-4a64-8d96-51320f27d83f

> Inspection records and compliance data for Lupin Pharmaceuticals Inc. in Baltimore, Maryland. 4 FDA inspections on record, last inspected May 23, 2014.

---

## Details

- Name: Lupin Pharmaceuticals Inc.
- FEI Number: 3004097115
- Address Line 1: 111 S Calvert St Fl 21st, Harborplace Tower
- City: Baltimore
- State: Maryland
- Zip Code: 21202
- Country Name: United States
- Address: 111 S Calvert St Fl 21st, Harborplace Tower, Baltimore, Maryland 21202, United States
- Country: United States

## Related Documents

- [FDA Inspection 880292 - Lupin Pharmaceuticals Inc. - 2014-05-23](https://www.keypedia.com/records/fda_inspections/lupin-pharmaceuticals-inc/38d75363-3dcb-479e-83f7-d1dc4f8729ca) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 23, 2014
- [FDA Inspection 761230 - Lupin Pharmaceuticals Inc. - 2011-12-23](https://www.keypedia.com/records/fda_inspections/lupin-pharmaceuticals-inc/9f4dc337-5966-4a49-8108-18311e249ba0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 23, 2011
- FDA Inspection 718224 - Lupin Pharmaceuticals Inc. - 2011-04-06 — classification: No Action Indicated (NAI), source: FDA, date: April 6, 2011
- FDA Inspection 572735 - Lupin Pharmaceuticals Inc. - 2009-02-27 — classification: No Action Indicated (NAI), source: FDA, date: February 27, 2009

## Related Companies

- [Lawrence W. Adler, MD](https://www.keypedia.com/companies/lawrence-w-adler-md/b1b711d3-1262-42bb-b18d-cfbfcc84f4db)
- [Welgo LLC](https://www.keypedia.com/companies/welgo-llc/31329520-c7ee-4c9c-bb06-857c3bfdd1e9)
- [Maryland Respiratory Group](https://www.keypedia.com/companies/maryland-respiratory-group/0d0da0f1-5daa-46e4-9d2e-984a8d40cb93)
- [Sharon M. Henry, MD](https://www.keypedia.com/companies/sharon-m-henry-md/8d7ce1b6-6ab6-4d2b-8a93-600cb4b227b5)
- [KAI Research, Inc.](https://www.keypedia.com/companies/kai-research-inc/5672fda2-234f-41f3-ac71-60b3a05a4793)
- [OncoImmune, Inc](https://www.keypedia.com/companies/oncoimmune-inc/af298ed0-664e-4564-a05e-dca399c7a841)
- [MaGil IRB](https://www.keypedia.com/companies/magil-irb/127b8c86-e510-47e9-8d62-2a038c80bf8a)
- [National Institute of Health RDRC](https://www.keypedia.com/companies/national-institute-of-health-rdrc/08f2e34c-824b-4a50-8ada-7286c98efa41)
- [extenCARE Inc.](https://www.keypedia.com/companies/extencare-inc/1dc074e7-8ddd-44c5-b717-d0efbc520de7)
- [Brigitte C Widemann Md](https://www.keypedia.com/companies/brigitte-c-widemann-md/4b3f8bfd-3c1d-4afb-88f6-b7bbd7e84e4e)
